I manage quality compliance at Medline. In a typical year, I review samples and documentation for roughly 300 product SKUs, masks, gowns, monitors, diagnostics, patient care equipment, before they go out to customers. In 2024 I rejected around 8% of first production submissions. Not all of those products were broken. Many were mismatched: the product met the paperwork, but the paperwork did not meet the actual job.
That is why, in my opinion, quality is not a property of a device. It is an agreement between what a clinical team actually does and what the product is designed to do. The best way to make that agreement hold is not to trust a brand blindly, even ours. It is to ask harder questions before ordering.
Quality is not a property of the product. It is an agreement between what a clinical team needs and what the product actually does. The sharper the buyer, the stronger the agreement.
The Simple Product Test: Surgical Masks
Start with something that looks simple. A Medline surgical mask can feel like a commodity. It is not. There are different lines and different performance levels. In the US market, most surgical masks are described against ASTM F2100, and those levels matter more than most buyers realize.
Level 1 is suited to low-risk, low-fluid procedures. Level 2 offers moderate fluid resistance. Level 3 is meant for procedures with higher fluid exposure. A higher level is not automatically better; it can be less breathable and more expensive. I have seen procurement teams treat the levels like school grades, assuming Level 3 should be used everywhere. I get why they do it, standardization feels safer. But buying the strongest mask for every situation creates a different problem: staff discomfort, unnecessary cost, and a false sense that protection is a single number.
Confession from a quality person: I knew I should pull a physical sample from every production lot and measure the nose wire placement, not just trust the certification. But we had received five clean lots from one supplier, and I thought the odds of a problem were low. That was the one time the odds caught up. The nose wire placement had drifted by about 5 millimeters from our specification. The masks were not unsafe, but after twenty minutes of wear they fogged more easily and did not fit the way clinicians expected. The vendor pointed to industry tolerance and said the masks were acceptable. We disagreed and required a rework at their cost.
An informed buyer prevents that kind of issue before it starts. You do not need a full quality lab. You need to know which procedure the mask is for, what fluid exposure is likely, and what breathability your staff will tolerate. Then ask the supplier to show, not just claim, how their mask matches those conditions.
A Wrist Monitor Teaches a Different Lesson
Now look at the Medline digital wrist blood pressure monitor. In our lab, it performs well. The pressure readings stay within expected tolerances when tested against a reference cuff. On paper, the product does its job.
In real life, the results can look much worse than the hardware. A wrist monitor requires the cuff to be at heart level during measurement. If a patient sits with the wrist resting below heart level, the reading can drift upward. If the cuff is the wrong size, the sensor may still measure pressure, but the number becomes less meaningful. This is not a manufacturing defect. It is a method issue. From my perspective, the device and the user are part of one system, and quality fails when the two do not match.
Looking back on one home care complaint from 2023, I should have asked how the hospital taught their patients to position the cuff before we processed a return credit. At the time, it looked simpler to replace the device. The replacement changed nothing, because the device was not the problem. The user had not been shown how to use it in the right position.
What would have helped? A quick start card, a short training video, or a supplier who asks about the patient's physical abilities before recommending a wrist model. That is why I would rather spend ten minutes explaining options than deal with mismatched expectations later.
ICU Monitors, Multi-Parameter Monitors, and the Real Cost of Gaps
The same idea gets more expensive when you move to capital equipment. An ICU monitor, often called a multi-parameter monitor, is not just a screen with vital signs on it. It is a whole chain: ECG leads, SpO2 sensors, blood pressure cuffs, temperature probes, alarms, network connections, and staff who have to interpret all of it in a noisy environment.
Buyers usually compare screen size, parameter count, and price. Those matter. But the quiet failures happen elsewhere. If the leads are incompatible with the hospital's existing stock, the monitoring system becomes harder to maintain. If the alarm defaults are not configured for the patient population, the device can be too quiet or too loud. If no one owns the training process, a capable monitor can sit in a unit half-understood.
The same logic applies to point of care testing. I hear the phrase constantly. What is point of care testing? Technically, it is diagnostic testing performed at or near the site of patient care, such as a glucose meter at the bedside, a blood gas analyzer in the emergency department, or an INR device in a clinic. The name makes it sound like a product category. In practice, POC testing is a process, not a device.
The instrument is only one piece. You need quality control materials, operator training, documentation, storage conditions, and a clear policy for what happens when a result falls outside the expected range. I have been in conversations where a facility wanted to buy a POC analyzer but had not assigned anyone to run quality controls. That worries me more than any hardware specification.
When a buyer asks what point of care testing will involve beyond the machine, the whole conversation improves. That buyer is not difficult. That buyer is doing quality assurance before the purchase order is signed.
Would Not a Less Informed Customer Be Easier to Sell To?
It is fair to ask whether a supplier secretly prefers buyers who do not ask too many questions. Some suppliers probably do. They want to sell features, ship the order, and move on. That approach creates returns, rework, and unhappy clinicians. It also damages trust, and in medical supply, trust is slow to rebuild.
From my perspective, an educated customer is not a burden. An informed customer asks better questions and makes faster decisions. When you understand what a mask level means, you can choose the right product the first time. When you understand how a wrist monitor is used, you can train your team before problems appear. When you understand what point of care testing requires, you build a program instead of just placing a device on a counter.
To be fair, asking harder questions can slow down an RFP. I know procurement teams are under pressure to keep things moving. But the slowdown at the front end is often faster than the correction at the back end. I would rather answer ten questions before a shipment than be remembered for the one shipment that did not match the real need.
Ask More, Not Less
At Medline, my team checks product consistency, labeling, documentation, and packaging. We do that because we know the cost of a surprise is high. But we are only half of the quality system. The other half is the buyer who knows enough to ask: What exactly is this product designed to do? How do we train our staff? What happens if the real conditions differ from the brochure?
In my opinion, those questions are not a sign of distrust. They are a sign of professionalism. The strongest medical supply relationships are built on informed customers who expect verification, and suppliers who respect them enough to provide it.
So ask more. Ask us about surgical mask levels, blood pressure monitor positioning, multi-parameter monitor compatibility, and point of care testing workflows. We will be better for it, and so will your patients.
